EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|14|1293-1301

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.14, 2014-12, pp. : 1293-1301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCR2: a target for pancreatic cancer treatment?

By Hertzer Kathleen M   Donald Graham W   Hines O Joe  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 667-680

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. : 2404-2415

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

By  

Current Cancer Drug Targets, Vol. 17, Iss. 1, 2016-12 ,pp. : 89-97

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches to Target Pancreatic Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 6, 2011-01 ,pp. : 698-713

Bentham Science Publishers

Access to resources Recommend Favorite

Leptin as a potential therapeutic target for breast cancer prevention and treatment

By Ray Amitbha   Cleary Margot P  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 4, 2010-04 ,pp. : 443-451

Informa Healthcare

Access to resources Recommend Favorite